S 6925

New York Senate bill in Session 2025-2026.

Status: in_committee. Latest action: March 27, 2025.

Relates to capping cost sharing for antiviral COVID-19 therapeutics.

Bill ID NY-2025-2026-S-6925
Session 2025-2026
Status in_committee
Committee Insurance
Senate in_committee 2025-03-27
Summary

Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.

Sponsor
Brad Hoylman-Sigal
Official Source Back to Bills
Actions Timeline
Date Event Detail
2025-03-27 Introduced Bill introduced
2025-03-27 Status in_committee
2025-03-27 Latest Action In Senate Committee
More Bills From This Sponsor
More Bills In This Topic
Related Topics
Same Topic Bills From Other States